The slots were a big chunk of SV earnings when Vendor ran it. Don't have the numbers off the top of my head, but that's where the improvement nedds to come from. VIP turnover is on a run rate of 80B pa which isn't to bad, but clearly 'refreshing' the slots offering hasn't had the desired effect yet. It sounded great, but slots players can be a fickle bunch. Big payers often like 'their' machine.
DNA Price at posting:
8.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)